跳至主要内容
临床试验/NCT02264600
NCT02264600Unknown不适用

Oxidative Stress and Apelin Level in Willis Ekbom Disease

Acibadem University0 个研究点目标入组 30 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
主要终点
Serum apelin level in WED patients and healthy controls

研究概览

简要总结

The purpose of this study is to assess apelin level in patients with Willis-Ekbom Disease (WED) as known Restless Legs Syndrome (RLS). Cardiovascular complications of WED have been reported in recent studies. Increased oxidative stress is thought to play an important role in cardiovascular complications of WED patients. Apelin is a novel described antioxidant bioactive peptide. The investigators hypothesize that patients with WED have lower plasma apelin level than healthy subjects based on presence of oxidative stress of WED.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed as RLS/WED according to International Classification of Sleep Disorders (ICSD-3) criteria
  • Patients with idiopathic RLS/WED
  • Moderate and severe RLS/WED according to International Restless Legs Syndrome Rating Scale
  • Periodic Leg Movements Index above 5 in polysomnography record
  • BMI below 25

排除标准

  • Disorders which cause symptomatic RLS(Iron deficiency anemia, kidney failure, diabetes mellitus, pregnancy, Parkinson's disease, multiple sclerosis, neuropathy)
  • Systemic diseases which cause possible oxidative stress status (cardiovascular diseases, obesity, diabetes mellitus, use of any medical drugs especially ACE inhibitors e.g.)
  • Another sleep disorder

结局指标

主要结局

Serum apelin level in WED patients and healthy controls

时间窗: Two months

次要结局

未报告次要终点

研究者

发起方
Acibadem University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Selda Korkmaz

Principal Investigator

Acibadem University

相似试验

Apelin in Willis Ekbom Disease | 临床试验